Synthetic receptors for control and specific treatment of renal cell carcinoma with car t cells

TW202635726APending Publication Date: 2026-09-01LINK CELL THERAPIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141692
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-08-12
Filing Date
2025-10-28
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074517_001
    Figure TWG2TA001074517_001
  • Figure TWG2TA001074517_002
    Figure TWG2TA001074517_002
  • Figure TWG2TA001074517_003
    Figure TWG2TA001074517_003
Patent Text Reader

Abstract

Provided herein are antibodies and antibody fragments that bind CA9 or ENPP3. Also provided are methods of treating clear cell renal cell carcinoma with an antibody or antibody fragment that binds CA9 and an antibody or antibody fragment that binds ENPP3.
Need to check novelty before this filing date? Find Prior Art